×
Utah Medical Products Net Profit Margin 2010-2024 | UTMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Utah Medical Products net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Utah Medical Products Net Profit Margin 2010-2024 | UTMD
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Utah Medical Products net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$202.2B
Stryker (SYK)
$143.3B
Boston Scientific (BSX)
$130.1B
Medtronic (MDT)
$112.5B
EssilorLuxottica (ESLOY)
$111.7B
Lonza Group Ag (LZAGY)
$45.4B
Haleon (HLN)
$43.5B
GE HealthCare Technologies (GEHC)
$39.3B
ResMed (RMD)
$37B
Terumo (TRUMY)
$29.6B
Koninklijke Philips (PHG)
$25B
Zimmer Biomet Holdings (ZBH)
$21.5B
Insulet (PODD)
$18.8B
Baxter (BAX)
$17.7B
Smith & Nephew SNATS (SNN)
$10.6B
Bio-Rad Laboratories (BIO)
$10.3B
BellRing Brands (BRBR)
$9.1B
Demant (WILYY)
$8.4B
Lantheus Holdings (LNTH)
$6.1B
Haemonetics (HAE)
$4.5B
TG Therapeutics (TGTX)
$4.5B
ICU Medical (ICUI)
$4.3B
Prestige Consumer Healthcare (PBH)
$4B
Perrigo (PRGO)
$3.6B
Neogen (NEOG)
$3.5B
Envista Holdings (NVST)
$3.5B
Agios Pharmaceuticals (AGIO)
$3.4B
GN Store Nord (GNNDY)
$3B
Shandong Weigao Medical Polymer (SHWGF)
$3B
QuidelOrtho (QDEL)
$2.9B